INMUNE BIO INC. (INMB) Operating cash flow 2017–2025
INMUNE BIO INC. (INMB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.6MFY2025 · since FY2017: -$761,834 → -$22.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.6M | +32.3% |
| FY2024 | -$33.4M | -178.5% |
| FY2023 | -$12.0M | +47.2% |
| FY2022 | -$22.7M | +20.4% |
| FY2021 | -$28.5M | -218.7% |
| FY2020 | -$8.9M | -66.1% |
| FY2019 | -$5.4M | -161.5% |
| FY2018 | -$2.1M | -170.3% |
| FY2017 | -$761,834 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INMB financial trends
INMB RevenueINMB Net incomeINMB Net marginINMB Gross profitINMB Gross marginINMB Operating incomeINMB Operating marginINMB Free cash flowINMB Capital expendituresINMB Return on equityINMB Stock buybacksINMB Dividends paidINMB Total assetsINMB Total liabilitiesINMB Shareholders’ equityINMB overview →